Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

Document Sample
Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry Powered By Docstoc
					                                Pharmaceutical
                                             Panel Report




Global Pharmaceutical Survey 2012–
2013:
Market Trends, Buyer Spend and Procurement
Strategies in the Global Pharmaceutical Industry

Reference code: PH1615PR

Published: March 2012


ICD Research

John Carpenter House
7 Carmelite Street
London EC4Y 0BS
United Kingdom
Tel: +44 (0) 20 7936 6400
Fax: +44 (0) 20 7336 6813
Website: www.icd-research.com




                                      www.icd-research.com
 TABLE OF CONTENTS



TABLE OF CONTENTS

1      Introduction ........................................................................................................................... 9
    1.1 What is This Report About? ............................................................................................................. 9
    1.2 Definitions ........................................................................................................................................ 9
    1.3 Methodology ...................................................................................................................................10
    1.4 Profile of Survey Respondents: Global Pharmaceutical Industry .....................................................12
        1.4.1     Profile of buyer respondents: global pharmaceutical industry .................................................................. 12
        1.4.2     Profile of supplier respondents: global pharmaceutical industry .............................................................. 13
2      Executive Summary ............................................................................................................ 15
3      Global Pharmaceutical Industry Dynamics ....................................................................... 17
    3.1 Revenue Growth Expectations in the Global Pharmaceutical Industry ............................................18
        3.1.1     Global pharmaceutical industry: revenue growth expectations by company type ................................... 20
        3.1.2     Global pharmaceutical industry: revenue growth expectations by region ................................................ 22
        3.1.3     Global pharmaceutical industry: revenue growth expectations by turnover ............................................. 24
        3.1.4     Global pharmaceutical industry: revenue growth expectations by senior level respondents ................... 25
        3.1.5     Global pharmaceutical industry: Revenue growth expectations-cross industry comparisons ................. 26
    3.2 Future Developments in Business Structure: Global Pharmaceutical Industry .................................27
        3.2.1     Global pharmaceutical industry: future developments by buyers ............................................................. 27
        3.2.2     Global pharmaceutical industry: future developments by suppliers ......................................................... 31
        3.2.3     Global pharmaceutical industry: future developments by region.............................................................. 32
        3.2.4     Global pharmaceutical industry: future developments by company turnover ........................................... 33
    3.3 M&A Activity Projections in the Global Pharmaceutical Industry ......................................................35
        3.3.1     M&A activity projections in the global pharmaceutical industry by buyers ............................................... 35
        3.3.2     M&A activity projections in the global pharmaceutical industry by suppliers ........................................... 39
        3.3.3     M&A activity projections in the global pharmaceutical industry by region ................................................ 41
        3.3.4     M&A activity projections in the global pharmaceutical industry by company turnover ............................. 42
        3.3.5     Global pharmaceutical industry: expansion abroad vs M&A activity projections ..................................... 43
    3.4 Capital Expenditure Forecast in the Global Pharmaceutical Industry...............................................44
        3.4.1     Capital expenditure forecast in the global pharmaceutical industry by buyers ........................................ 44
        3.4.2     Capital expenditure forecast in the global pharmaceutical industry by suppliers ..................................... 47
        3.4.3     Capital expenditure forecast in the global pharmaceutical industry by region ......................................... 49
        3.4.4     Capital expenditure forecast in the global pharmaceutical industry by company turnover ...................... 50
    3.5 Planned Change in Staff Recruitment Activity: Global Pharmaceutical Industry ..............................51
        3.5.1     Global pharmaceutical industry: planned change in staff recruitment activity by buyers ......................... 51
        3.5.2     Global pharmaceutical industry: planned change in staff recruitment activity by suppliers ..................... 52
        3.5.3     Global pharmaceutical industry: planned change in staff recruitment activity by region .......................... 54
        3.5.4     Global pharmaceutical industry: planned change in staff recruitment activity by company turnover ....... 55


Global Pharmaceutical Industry Survey 2012–2013:Market Trends, Buyer Spend and
                                                                                                                                                      Page 2
Procurement Strategies in the Global Pharmaceutical Industry

© ICD Research. This product is licensed and is not to be photocopied                                                                Published: March 2012
 TABLE OF CONTENTS


4      Global Pharmaceutical Industry Market Growth Outlook ................................................ 56
    4.1 Global Pharmaceutical Industry: Demand in Emerging Markets ......................................................58
       4.1.1    Global pharmaceutical industry: demand in emerging markets by buyers ............................................... 58
       4.1.2    Global pharmaceutical industry: demand in emerging markets by suppliers ........................................... 62
       4.1.3    Global pharmaceutical industry: demand in emerging markets by region ............................................... 64
       4.1.4    Global pharmaceutical industry: demand in emerging markets by company turnover ............................ 65
    4.2 Global Pharmaceutical Industry: Growth Expectations in Developed Countries ..............................66
       4.2.1    Global pharmaceutical industry: growth expectations in developed countries by buyers ........................ 66
       4.2.2    Global pharmaceutical industry: growth expectations in developed countries by suppliers .................... 71
       4.2.3    Global pharmaceutical industry: growth expectations in developed countries by region ......................... 73
       4.2.4    Global pharmaceutical industry: growth expectations in developed countries by company turnover ...... 74
5      Threats and Opportunities for the Global Pharmaceutical Industry ............................... 75
    5.1 Global Pharmaceutical Industry: Leading Business Concerns for 2012–2013 .................................76
       5.1.1    Global pharmaceutical industry: leading business concerns for 2012–2013 by company type ............... 78
       5.1.2    Global pharmaceutical industry: leading business concerns for 2012–2013 by region ........................... 80
       5.1.3    Global pharmaceutical industry: leading business concerns for 2012–2013 by company turnover ........ 81
    5.2 Global Pharmaceutical Industry: Key Supplier Actions to Secure Buyer Business...........................82
       5.2.1    Global pharmaceutical industry: key actions to secure buyer business (buyer respondents) ................. 84
       5.2.2    Global pharmaceutical industry: key actions to secure buyer business by region ................................... 86
       5.2.3    Global pharmaceutical industry: key actions to secure buyer business by turnover ................................ 88
       5.2.4    Global pharmaceutical industry: key actions to secure buyer business by procurement budget ............. 90
       5.2.5    Global pharmaceutical industry: key actions to secure buyer business by purchasing decision authority91
6      Global Pharmaceutical Industry Buyer Spend Activity .................................................... 92
    6.1 Global Pharmaceutical Industry: Annual Procurement Budgets.......................................................93
       6.1.1    Global pharmaceutical industry: annual procurement budgets by company type .................................... 94
       6.1.2    Global pharmaceutical industry: annual procurement budgets by region ................................................ 95
       6.1.3    Global pharmaceutical industry: annual procurement budgets by company turnover ............................. 96
    6.2 Global Pharmaceutical Industry: Planned Change in Procurement Spend ......................................97
       6.2.1    Global pharmaceutical industry: planned change in procurement spend by buyer type .......................... 99
       6.2.2    Global pharmaceutical industry: planned change in procurement spend by region .............................. 100
       6.2.3    Global pharmaceutical industry: planned change in procurement spend by company turnover ............ 102
       6.2.4    Global pharmaceutical industry: planned change in expenditure vs. revenue growth optimism ............ 104
       6.2.5    Global pharmaceutical industry: planned change in expenditure vs. cost containment ......................... 104
       6.2.6    Global pharmaceutical industry: planned change in procurement spend – cross industry comparisons105
    6.3 Planned change in procurement spend by product and service category ......................................106
       6.3.1    Planned change in procurement spend by product and service category - region ................................ 111
       6.3.2    Planned change in procurement spend by product and service category - company turnover ............. 112
    6.4 Global Pharmaceutical Industry: Variations in Regional Supplier Prices ........................................113


Global Pharmaceutical Industry Survey 2012–2013:Market Trends, Buyer Spend and
                                                                                                                                 Page 3
Procurement Strategies in the Global Pharmaceutical Industry

© ICD Research. This product is licensed and is not to be photocopied                                             Published: March 2012
 TABLE OF CONTENTS


       6.4.1      Global pharmaceutical industry: variations in regional supplier prices by company type ...................... 114
       6.4.2      Global pharmaceutical industry: variations in supplier prices by region ................................................. 116
       6.4.3      Global pharmaceutical industry: variations in regional supplier prices by company turnover ................ 117
7     
				
DOCUMENT INFO
Description: • This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey. • The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa and Middle East. • The report covers data and analysis on buyer expenditure, procurement and industry developments. • Key topics covered include pharmaceutical industry buyer expenditure activity, procurement behaviors and strategies, threats and opportunities, economic outlook and business confidence. • In the report, buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats. • The report examines current practices and provides future expectations over the next 12–24 months. • The report provides qualitative analysis of the key industry threats and opportunities and contains full survey results.
BUY THIS DOCUMENT NOW PRICE: $2000 100% MONEY BACK GUARANTEED
PARTNER ICD Research
With emphasis on Insight, Consultancy and Delivery, iCD Research is a full-service, online market research agency. iCD Research is able to take advantage of all of the efficiencies and benefits that the Internet brings to offer proven research methodologies with fast turnaround and accurate results. iCD Research specialises in qualitative research for large finance, media, retail and entertainment clients. Market leaders in online focus groups, iCD Research has unleashed the full scale of the Internet to run focus groups across the globe for its major institutional clients. Utilising its sister organisation, The iD Factor, iCD Research also delivers strong quantitative research, ranging from ongoing consumer confidence studies through to consumer surveys throughout Europe and Asia. With its roots firmly in research, iCD Research doesn’t limit itself to only utilising online methods as the philosophy at the company is to match the methodology to the respondent. Yet the scale and speed of online research give iCD Research a cutting edge that has lead to tremendous, triple-figure percentage growth over the past two years. iCD Research is headquartered in London, with operational offices in the US and Australia to ensure that it is offering an unparalleled 24 hour service to its clients.